126 related articles for article (PubMed ID: 18713130)
1. Searching for the Achilles' heel of melanoma cells: new treatment modalities.
Melnikova VO; Bar-Eli M
Pigment Cell Melanoma Res; 2008 Oct; 21(5):505-6. PubMed ID: 18713130
[No Abstract] [Full Text] [Related]
2. Reactive oxygen species may have antitumor activity in metastatic melanoma.
Tuma RS
J Natl Cancer Inst; 2008 Jan; 100(1):11-2. PubMed ID: 18159075
[No Abstract] [Full Text] [Related]
3. [Clinical studies with sorafenib (Nexavar) in metastatic melanoma].
Hauschild A
J Dtsch Dermatol Ges; 2007 Apr; 5(4):345. PubMed ID: 17376105
[No Abstract] [Full Text] [Related]
4. Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect.
Lopez V; Pinazo I; Marti N; Monteagudo C; Jorda E
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):959-60. PubMed ID: 18785888
[No Abstract] [Full Text] [Related]
5. Azidothymidine inhibits melanoma cell growth in vitro and in vivo.
Humer J; Ferko B; Waltenberger A; Rapberger R; Pehamberger H; Muster T
Melanoma Res; 2008 Oct; 18(5):314-21. PubMed ID: 18781129
[TBL] [Abstract][Full Text] [Related]
6. PBISe, a novel selenium-containing drug for the treatment of malignant melanoma.
Madhunapantula SV; Desai D; Sharma A; Huh SJ; Amin S; Robertson GP
Mol Cancer Ther; 2008 May; 7(5):1297-308. PubMed ID: 18483317
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.
Jariwalla RJ; Gangapurkar B; Nakamura D
Br J Nutr; 2009 Jan; 101(2):182-9. PubMed ID: 18549510
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?
Kim KB
Cancer; 2013 Feb; 119(3):477-80. PubMed ID: 22915026
[No Abstract] [Full Text] [Related]
9. Reactive oxygen species: an Achilles' heel of melanoma?
Fruehauf JP; Trapp V
Expert Rev Anticancer Ther; 2008 Nov; 8(11):1751-7. PubMed ID: 18983235
[TBL] [Abstract][Full Text] [Related]
10. The new arms race against melanoma.
Lejeune FJ
Melanoma Res; 2006 Feb; 16(1):1-2. PubMed ID: 16432449
[No Abstract] [Full Text] [Related]
11. Thymidylate synthase inhibitors.
Ackland SP; Clarke SJ; Beale P; Peters GJ
Cancer Chemother Biol Response Modif; 2002; 20():1-36. PubMed ID: 12703198
[No Abstract] [Full Text] [Related]
12. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
Hemrajani RH; Kim KB; Amos WR; Mann DE
Melanoma Res; 2007 Aug; 17(4):257-9. PubMed ID: 17625458
[No Abstract] [Full Text] [Related]
13. [Melanoma and non-melanoma skin cancers].
Saito T
Gan To Kagaku Ryoho; 2008 Apr; 35(4):583. PubMed ID: 18467999
[No Abstract] [Full Text] [Related]
14. Novel treatment strategies for malignant melanoma: a new beginning?
Kasper B; D'Hondt V; Vereecken P; Awada A
Crit Rev Oncol Hematol; 2007 Apr; 62(1):16-22. PubMed ID: 17208006
[TBL] [Abstract][Full Text] [Related]
15. [In vitro drug sensitivity profiling in melanoma].
Ugurel S
J Dtsch Dermatol Ges; 2008 Jul; 6(7):611. PubMed ID: 18611186
[No Abstract] [Full Text] [Related]
16. Dual fronts poised to transform melanoma therapy.
Mullard A
Nat Rev Drug Discov; 2011 May; 10(5):325-6. PubMed ID: 21532549
[No Abstract] [Full Text] [Related]
17. Antiangiogenic and antiapoptotic treatment in advanced melanoma.
Nikolaou V; Stratigos A; Bafaloukos D; Katsambas A
Clin Dermatol; 2013; 31(3):257-63. PubMed ID: 23608445
[TBL] [Abstract][Full Text] [Related]
18. In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation.
Rossi T; Coppi A; Bruni E; Sgobba M; Degliesposti G; Rastelli G
ChemMedChem; 2008 Mar; 3(3):421-4. PubMed ID: 17973282
[No Abstract] [Full Text] [Related]
19. [Conclude that clinical trials on the overall effectiveness of interferon? Contribution of recent data].
Boulinguez S; Grange F
Ann Dermatol Venereol; 2011 May; 138(5 Suppl 1):H21-4. PubMed ID: 21703461
[No Abstract] [Full Text] [Related]
20. Nivolumab success in untreated metastatic melanoma.
Wilkinson E
Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638562
[No Abstract] [Full Text] [Related]
[Next] [New Search]